Edge SB - Search Results

1

Mammographic predictors of the presence and size of invasive carcinomas associated with malignant microcalcification lesions without a mass.

Stomper PC, Geradts J, Edge SB, Levine EG. Stomper PC, et al. Among authors: edge sb. AJR Am J Roentgenol. 2003 Dec;181(6):1679-84. doi: 10.2214/ajr.181.6.1811679. AJR Am J Roentgenol. 2003. PMID: 14627596

2

Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features.

Stomper PC, Herman S, Klippenstein DL, Winston JS, Edge SB, Arredondo MA, Mazurchuk RV, Blumenson LE. Stomper PC, et al. Among authors: edge sb. Radiology. 1995 Nov;197(2):387-95. doi: 10.1148/radiology.197.2.7480682. Radiology. 1995. PMID: 7480682

3

Therapy for inflammatory breast cancer: impact of doxorubicin-based therapy.

Bauer RL, Busch E, Levine E, Edge SB. Bauer RL, et al. Among authors: edge sb. Ann Surg Oncol. 1995 Jul;2(4):288-94. doi: 10.1007/BF02307059. Ann Surg Oncol. 1995. PMID: 7552616

4

Lobular carcinoma in situ: observation without surgery as an appropriate therapy.

Carson W, Sanchez-Forgach E, Stomper P, Penetrante R, Tsangaris TN, Edge SB. Carson W, et al. Among authors: edge sb. Ann Surg Oncol. 1994 Mar;1(2):141-6. doi: 10.1007/BF02303558. Ann Surg Oncol. 1994. PMID: 7834439

5

Cellular proliferative activity of mammographic normal dense and fatty tissue determined by DNA S phase percentage.

Stomper PC, Penetrante RB, Edge SB, Arredondo MA, Blumenson LE, Stewart CC. Stomper PC, et al. Among authors: edge sb. Breast Cancer Res Treat. 1996;37(3):229-36. doi: 10.1007/BF01806504. Breast Cancer Res Treat. 1996. PMID: 8825134

6

Down-regulation of gelsolin expression in human breast ductal carcinoma in situ with and without invasion.

Asch HL, Winston JS, Edge SB, Stomper PC, Asch BB. Asch HL, et al. Among authors: edge sb. Breast Cancer Res Treat. 1999 May;55(2):179-88. doi: 10.1023/a:1006203632228. Breast Cancer Res Treat. 1999. PMID: 10481945

7

Postexcision mammography is indicated after resection of ductal carcinoma-in-situ of the breast.

Waddell BE, Stomper PC, DeFazio JL, Hurd TC, Edge SB. Waddell BE, et al. Among authors: edge sb. Ann Surg Oncol. 2000 Oct;7(9):665-8. doi: 10.1007/s10434-000-0665-x. Ann Surg Oncol. 2000. PMID: 11034243

8

Downregulation of gelsolin correlates with the progression to breast carcinoma.

Winston JS, Asch HL, Zhang PJ, Edge SB, Hyland A, Asch BB. Winston JS, et al. Among authors: edge sb. Breast Cancer Res Treat. 2001 Jan;65(1):11-21. doi: 10.1023/a:1006446108411. Breast Cancer Res Treat. 2001. PMID: 11245335

9

Breast MRI in the Evaluation of Patients with Occult Primary Breast Carcinoma.

Stomper PC, Waddell BE, Edge SB, Klippenstein DL. Stomper PC, et al. Among authors: edge sb. Breast J. 1999 Jul;5(4):230-234. doi: 10.1046/j.1524-4741.1999.99004.x. Breast J. 1999. PMID: 11348292

10

Is MUGA scan necessary in patients with low-risk breast cancer before doxorubicin-based adjuvant therapy? Multiple gated acquisition.

Sabel MS, Levine EG, Hurd T, Schwartz GN, Zielinski R, Hohn D, Edge SB. Sabel MS, et al. Among authors: edge sb. Am J Clin Oncol. 2001 Aug;24(4):425-8. doi: 10.1097/00000421-200108000-00027. Am J Clin Oncol. 2001. PMID: 11474280

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

260 results

Search Page

Filters